These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35785009)

  • 1. Description and Clinical Management of Patients With Glanzmann's Thrombasthenia in a University Hospital, a Referral Center Specialized in Hemostasis, in Bogotá, Colombia.
    Solano MH; Chaves K; Casas CP
    Cureus; 2022 Jun; 14(6):e25657. PubMed ID: 35785009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Insights Into the Treatment of Glanzmann Thrombasthenia.
    Poon MC; Di Minno G; d'Oiron R; Zotz R
    Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature.
    Rajpurkar M; Chitlur M; Recht M; Cooper DL
    Haemophilia; 2014 Jul; 20(4):464-71. PubMed ID: 24948404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glanzmann's thrombasthenia (defective platelet integrin alphaIIb-beta3): proposals for management between evidence and open issues.
    Di Minno G; Coppola A; Di Minno MN; Poon MC
    Thromb Haemost; 2009 Dec; 102(6):1157-64. PubMed ID: 19967146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey.
    Poon MC; D'Oiron R; Von Depka M; Khair K; Négrier C; Karafoulidou A; Huth-Kuehne A; Morfini M;
    J Thromb Haemost; 2004 Jul; 2(7):1096-103. PubMed ID: 15219192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia.
    Poon MC
    Thromb Haemost; 2021 Mar; 121(3):332-340. PubMed ID: 33124022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia.
    Franchini M; Lippi G
    Expert Rev Hematol; 2014 Dec; 7(6):733-40. PubMed ID: 25387838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
    Poon MC; Zotz R; Di Minno G; Abrams ZS; Knudsen JB; Laurian Y
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombasthenia.
    van Buuren HR; Wielenga JJ
    Dig Dis Sci; 2002 Sep; 47(9):2134-6. PubMed ID: 12353868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.
    Di Minno G
    Blood Rev; 2015 Jun; 29 Suppl 1():S26-33. PubMed ID: 26073366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery.
    Kale A; Bayhan G; Yalinkaya A; Yayla M
    J Perinat Med; 2004; 32(5):456-8. PubMed ID: 15493726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease Burden in Patients with Glanzmann's Thrombasthenia: Perspectives from the Glanzmann's Thrombasthenia Patient/Caregiver Questionnaire.
    Duncan A; Kellum A; Peltier S; Cooper DL; Saad H
    J Blood Med; 2020; 11():289-295. PubMed ID: 32982527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feminizing Genitoplasty in a young girl with Glanzmann's thrombasthenia-management of haemostasis.
    Turk KK; Nazir Z
    J Pak Med Assoc; 2020 Jun; 70(6):1084-1085. PubMed ID: 32810113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Glanzmann's Thrombasthenia in Tunisia: A Cohort Study.
    Elmahmoudi H; Achour M; Belhedi N; Ben Neji H; Zahra K; Meddeb B; Gouider E
    J Hematol; 2017 Sep; 6(2-3):44-48. PubMed ID: 32300391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry.
    Recht M; Rajpurkar M; Chitlur M; d'Oiron R; Zotz R; Di Minno G; Cooper DL; Poon MC
    Am J Hematol; 2017 Jul; 92(7):646-652. PubMed ID: 28370369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glanzmann's thrombasthenia: updated.
    Nair S; Ghosh K; Kulkarni B; Shetty S; Mohanty D
    Platelets; 2002 Nov; 13(7):387-93. PubMed ID: 12487785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difficulty in controlling heavy menstrual bleeding at menarche in a patient with Glanzmann's thrombasthenia.
    Kadowaki S; Makino S; Mohri Y; Awaguni H; Shinozuka J; Imashuku S
    Blood Coagul Fibrinolysis; 2021 Mar; 32(2):155-158. PubMed ID: 33196513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia.
    Poon MC
    Vasc Health Risk Manag; 2007; 3(5):655-64. PubMed ID: 18078017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method.
    Farsinejad A; Abolghasemi H; Kazemi A; Aghaiipour M; Hadjati E; Faranoush M; Jazebi M; Ala F
    Platelets; 2011; 22(5):321-7. PubMed ID: 21526886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative management of a pediatric patient with Glanzmann's thrombasthenia during adenoidectomy.
    Duman EN; Saylan S; Cekic B
    Rev Bras Anestesiol; 2012 Jul; 62(4):548-53. PubMed ID: 22793971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.